Advances in non-invasive approaches like liquid biopsies, ctDNA profiling, and next‑generation sequencing are reshaping the diagnostic landscape https://www.einpresswire.com/article/833261098/cancer-diagnostics-market-to-double-by-2033-surpassing-us-42-billion-amid-early-detection-demand